# Elevation Oncology, Inc.

Elevation Oncology, Inc. is a company headquartered in Boston, MA, United States.

## Company overview

- **Legal name:** Elevation Oncology, Inc.
- **Former names in filing history:** 14ner Oncology, Inc. (2019-07-19 to 2019-07-19)
- **Classification:** Company
- **Industry (SIC):** 2836 — Biological Products, (No Diagnostic Substances)
- **Headquarters:** Boston, MA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001783032

## About

Elevation Oncology, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001783032, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2025-03-06, it reported net income of USD -44,485,000; total assets of USD 95,626,000 for the fiscal period ended 2024-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2024 (period ended 2024-12-31)

- **Net income:** -$44.5M (USD -44,485,000)
- **Total assets:** $95.6M (USD 95,626,000)
- **Cash and equivalents:** $49.5M (USD 49,464,000)
- **Operating cash flow:** -$36.4M (USD -36,364,000)

### FY2023 (period ended 2023-12-31)

- **Net income:** -$45.7M (USD -45,704,000)
- **Total assets:** $89.1M (USD 89,091,000)
- **Cash and equivalents:** $49.3M (USD 49,255,000)
- **Operating cash flow:** -$56.2M (USD -56,180,000)

### FY2022 (period ended 2022-12-31)

- **Net income:** -$95.1M (USD -95,080,000)
- **Total assets:** $94.2M (USD 94,161,000)
- **Cash and equivalents:** $45.9M (USD 45,917,000)
- **Operating cash flow:** -$85.5M (USD -85,483,000)

### FY2021 (period ended 2021-12-31)

- **Net income:** -$32.0M (USD -32,039,000)
- **Total assets:** $149.5M (USD 149,494,000)
- **Cash and equivalents:** $146.3M (USD 146,284,000)
- **Operating cash flow:** -$30.2M (USD -30,167,000)

## Recent SEC filings

- Form 8-K — filed 2025-07-23 — period 2025-07-23 — 8-K
- Form 8-K — filed 2025-07-02 — period 2025-06-26 — 8-K
- Form 8-K — filed 2025-06-09 — period 2025-06-05 — FORM 8-K
- Form 8-K — filed 2025-05-15 — period 2025-05-15 — 8-K
- Form 10-Q — filed 2025-05-15 — period 2025-03-31 — 10-Q
- Form 8-K — filed 2025-05-05 — period 2025-05-02 — 8-K
- Form DEF 14A — filed 2025-04-24 — period 2025-06-05 — DEF 14A
- Form 8-K — filed 2025-04-04 — period 2025-04-03 — 8-K
- Form 8-K — filed 2025-04-01 — period 2025-03-31 — 8-K
- Form 8-K — filed 2025-03-20 — period 2025-03-20 — FORM 8-K
- Form 8-K — filed 2025-03-19 — period 2025-03-19 — 8-K
- Form 8-K — filed 2025-03-06 — period 2025-03-06 — 8-K

---

Updated: 2026-10-23T20:06:36Z

Canonical page: https://altss.com/profile/elevation-oncology-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology